These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6141186)

  • 1. The prolactin response to flutroline hydrochloride in schizophrenic patients.
    Kurland AA; Nagaraju A; Hanlon TE; Williams TG
    J Clin Pharmacol; 1983; 23(11-12):505-16. PubMed ID: 6141186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flutroline in the treatment of the schizophrenic patient.
    Kurland AA; Nagaraju A; Hanlon TE
    J Clin Pharmacol; 1982 Oct; 22(10):441-9. PubMed ID: 6129266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind comparison of three dosages of flutroline (CP-36,584) in the treatment of schizophrenia.
    McEvoy JP; Berney S; Wilson WH; Ban TA; Guy W
    Int Pharmacopsychiatry; 1980; 15(5):318-24. PubMed ID: 7021452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of tolerance to long-term neuroleptic treatment in dopamine tuberoinfundibular system.
    Chouinard G; Annable L; Jones BD; Collu R
    Acta Psychiatr Scand; 1981 Nov; 64(5):353-62. PubMed ID: 6126066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine tests during treatment with neuroleptic drugs I. Plasma prolactin response to haloperidol challenge.
    Kolakowska T; Braddock L; Wiles D; Franklin M; Gelder M
    Br J Psychiatry; 1981 Nov; 139():400-4. PubMed ID: 6120731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EEG and behavioral profile of flutroline (CP-36,584), a novel antipsychotic drug.
    Fink M; Irwin P
    Psychopharmacology (Berl); 1980; 72(1):67-71. PubMed ID: 6110218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum neuroleptic levels, prolactin levels, and relapse: a two-year study of schizophrenic outpatients.
    Faraone SV; Brown WA; Laughren TP
    J Clin Psychiatry; 1987 Apr; 48(4):151-4. PubMed ID: 2881923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine tests during treatment with neuroleptic drugs: I. Plasma prolactin response to chlorpromazine challenge.
    Kolakowska T; Fraser S; Franklin M; Knox J
    Psychopharmacology (Berl); 1981; 72(3):283-5. PubMed ID: 6111824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin shifts after neuroleptic withdrawal.
    Green AI; Faraone SV; Brown WA
    Psychiatry Res; 1990 Jun; 32(3):213-9. PubMed ID: 1975101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine tests during treatment with neuroleptic drugs. III. Plasma growth hormone and prolactin responses to apomorphine.
    Kolakowska T; Gelder M; Fraser S
    Br J Psychiatry; 1981 Nov; 139():408-12. PubMed ID: 6120733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of serum prolactin levels in schizophrenia: comparison of males and females.
    Kuruvilla A; Peedicayil J; Srikrishna G; Kuruvilla K; Kanagasabapathy AS
    Clin Exp Pharmacol Physiol; 1992 Sep; 19(9):603-6. PubMed ID: 1356671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum neuroleptic activity, prolactin, and tardive dyskinesia in schizophrenic outpatients.
    Csernansky JG; Kaplan J; Holman CA; Hollister LE
    Psychopharmacology (Berl); 1983; 81(2):115-8. PubMed ID: 6138793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of olanzapine and fluphenazine on plasma cortisol, prolactin and muscle rigidity in schizophrenic patients: a double blind study.
    Jakovljevic M; Pivac N; Mihaljevic-Peles A; Mustapic M; Relja M; Ljubicic D; Marcinko D; Muck-Seler D
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):399-402. PubMed ID: 17126974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin levels in male schizophrenic patients treated with risperidone and haloperidol: a double-blind and randomized study.
    Zhang XY; Zhou DF; Cao LY; Zhang PY; Wu GY; Shen YC
    Psychopharmacology (Berl); 2005 Feb; 178(1):35-40. PubMed ID: 15289996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naloxone in chronic schizophrenic patients: neuroendocrine and behavioral effects.
    Kleinman JE; Weinberger DR; Rogol A; Shiling DJ; Mendelson WB; Davis GC; Bunney WE; Wyatt RJ
    Psychiatry Res; 1982 Aug; 7(1):1-7. PubMed ID: 6127744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Initial clinical response to neuroleptic treatment and serum prolactin levels in acute schizophrenic psychoses].
    Fuentenebro de Diego F; Cabranes JA; Ramos Brieva J; López Jiménez MR; Santiesteban Requena C
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1981; 9(6):499-506. PubMed ID: 6129779
    [No Abstract]   [Full Text] [Related]  

  • 17. Selegiline in the treatment of sexual dysfunction in schizophrenic patients maintained on neuroleptics: a pilot study.
    Kodesh A; Weizman A; Aizenberg D; Hermesh H; Gelkopf M; Zemishlany Z
    Clin Neuropharmacol; 2003; 26(4):193-5. PubMed ID: 12897639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients.
    Szymanski S; Lieberman JA; Alvir JM; Mayerhoff D; Loebel A; Geisler S; Chakos M; Koreen A; Jody D; Kane J
    Am J Psychiatry; 1995 May; 152(5):698-703. PubMed ID: 7726309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of nalmefene augmentation in neuroleptic-stabilized schizophrenic patients.
    Rapaport MH; Wolkowitz O; Kelsoe JR; Pato C; Konicki PE; Pickar D
    Neuropsychopharmacology; 1993 Sep; 9(2):111-5. PubMed ID: 8105790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal and stimulated levels of prolactin, TSH and LH in serum of chronic schizophrenic patients, long-term treated with neuroleptics.
    Naber D; Ackenheil M; Laakman G; Fischer H; von Werder K
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Nov; 13(6):325-30. PubMed ID: 6111094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.